Combination of Probiotics and Natural Compounds to Treat Multiple Sclerosis via Warburg Effect
Anjali Kandiruthi Ravi, Saradhadevi Kuppusami Muthukrishnan
Advanced Pharmaceutical Bulletin · 2022
doi:10.34172/apb.2022.057 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS).It is an auto-immune disorder. Its usual symptoms are unique to each person. In MS lesionsvast fractions of pyruvate molecules are instantly transformed into lactate. This reprogrammingmechanism of glycolysis is known as the Warburg effect. MS has no efficient treatment yet.Hence, there is a requirement for profitable immunomodulatory agents in MS. Probioticsperform as an immunomodulator because they regulate the host’s immune responses. Itsefficacy gets enhanced for an extended period when it combines with prebiotics. In this review,we focus on the metabolic alterations behind the MS lesions via the Warburg effect, and alsosuggesting, the combined efficacy of prebiotics and probiotics for the effective treatment ofMS without side effects. The Warburg effect mechanism intensifies the infiltration of activatedT-cells and B-cells into the CNS. It provokes the inflammation process on the myelin sheath.The infiltration of immune cells can be inhibited by the combination therapy of probiotics andprebiotics. By this review, we can recommend that the idea of this combinational therapy cando miracles in the treatment of MS in the future.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.